An update from Innovotech ( (TSE:IOT) ) is now available.
Innovotech Inc. reported a record annual revenue for 2024, with an 86% increase in top-line revenue to $2,194,471 and a net income of $214,755, marking a significant turnaround from the previous year’s loss. The company’s strategic initiatives and the acquisition of Keystone Labs have contributed to this growth, strengthening its financial position and supporting future expansion and shareholder value.
More about Innovotech
Innovotech Inc. is a Canadian technology company with a diverse portfolio in specialized laboratory services, biotechnology, and proprietary intellectual property. It operates several subsidiaries, including Innovotech Labs Corporation, which provides antimicrobial testing devices and solutions, and Keystone Labs Inc., a DEL-accredited lab serving the pharmaceutical and industrial markets in Canada.
YTD Price Performance: -36.11%
Average Trading Volume: 15,286
Technical Sentiment Signal: Buy
Current Market Cap: C$5.97M
Find detailed analytics on IOT stock on TipRanks’ Stock Analysis page.